According to FDA prescribing information, alopecia was reported in 3.5% of patients taking Wegovy (semaglutide 2.4 mg) compared to 1.0% on placebo
KEY DETAILS Program starts July 1, 2026 Flat $50 patient copay No deductible Only 28- or 30-day fills A new PA is required when switching medications Prescribers do not need to be enrolled in Medicare, but cannot be on the CMS Preclusion List Please share this with prescribers, pharmacists, nurses, medical assistants, and prior authorization teams
In contrast, there are safety concerns that dietary carnitine may accelerate atherosclerosis via gut microbiota metabolites [16]
However, patients have reported unexpected and serious side effects and injuries
ZuoLPratherERStetskivMGarrisonDEMeadeJRPeaceTIet alInflammaging and oxidative stress in human diseases: from molecular mechanisms to novel treatments